Financials
- Market Capitalization 153.7 M
- Employee 29
- Founded 2015
- CEO N/A
- Website nrxpharma.com
- Headquarter Delaware, United States
- FIGI BBG00JCWDN63
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.03
ratio cours/chiffre d'affaires
47.35
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3736 | OTLK Outlook Therapeutics, Inc. - Common Stock | 0.64 USD | 0.00% | -3.03% | -28.09% | +55.15% | 155.81 M USD | ||
| 3739 | TNYA Tenaya Therapeutics, Inc. - Common Stock | 0.69 USD | -1.43% | -1.43% | -8.00% | -40.00% | 154.72 M USD | ||
| 3744 | INDP Indaptus Therapeutics, Inc. - Common Stock | 1.15 USD | -0.86% | -10.16% | -34.66% | -39.47% | 153.23 M USD | ||
| 3749 | LENZ LENZ Therapeutics, Inc. - Common Stock | 4.84 USD | +0.62% | +2.54% | -16.70% | -85.11% | 152.07 M USD |